Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13782
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPingaew R.
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorMandi P.
dc.contributor.authorNantasenamat C.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:26:28Z-
dc.date.available2021-04-05T03:26:28Z-
dc.date.issued2015
dc.identifier.issn9680896
dc.identifier.other2-s2.0-84937425435
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13782-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84937425435&doi=10.1016%2fj.bmc.2015.04.036&partnerID=40&md5=ded6150540b91998db68cccbfd84b0e8
dc.description.abstractAbstract A series of 1,4-disubstituted-1,2,3-triazoles (13-35) containing sulfonamide moiety were synthesized and evaluated for their aromatase inhibitory effects. Most triazoles with open-chain sulfonamide showed significant aromatase inhibitory activity (IC50 = 1.3-9.4 μM). Interestingly, the meta analog of triazole-benzene-sulfonamide (34) bearing 6,7-dimethoxy substituents on the isoquinoline ring displayed the most potent aromatase inhibitory activity (IC50 = 0.2 μM) without affecting normal cell. Molecular docking of these triazoles against aromatase revealed that the compounds could snugly occupy the active site of the enzyme through hydrophobic, π-π stacking, and hydrogen bonding interactions. The potent compound 34 was able to form hydrogen bonds with Met374 and Ser478 which were suggested to be the essential residues for the promising inhibition. The study provides compound 34 as a potential lead molecule of anti-aromatase agent for further development. © 2015 Elsevier Ltd.
dc.subject1,2,3 triazole derivative
dc.subject1,2,3 triazole sulfonamide derivative
dc.subject4 [[1 [3 [(3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject4 [[1 [3 [(6,7 dimethoxy 3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject7 [[1 [3 [(3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject7 [[1 [3 [(6,7 dimethoxy 3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subjectaromatase inhibitor
dc.subjectcoumarin oxymethyl
dc.subjectfunctional group
dc.subjectketoconazole
dc.subjectletrozole
dc.subjectnaphthalene oxymethyl
dc.subjectphenoxymethyl
dc.subjectphenyl group
dc.subjectsulfonamide
dc.subjectsulfonyl group
dc.subjectunclassified drug
dc.subjectantineoplastic agent
dc.subjectaromatase
dc.subjectaromatase inhibitor
dc.subjectCYP19A1 protein, human
dc.subjectisoquinoline derivative
dc.subjectprotein binding
dc.subjectsulfonamide
dc.subjecttriazole derivative
dc.subjectanimal cell
dc.subjectArticle
dc.subjectbinding affinity
dc.subjectbinding site
dc.subjectcarbon nuclear magnetic resonance
dc.subjectchemical interaction
dc.subjectchemical reaction
dc.subjectClick reaction
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectdrug cytotoxicity
dc.subjectdrug mechanism
dc.subjectdrug potency
dc.subjectdrug safety
dc.subjectdrug screening
dc.subjectdrug synthesis
dc.subjectenzyme active site
dc.subjectenzyme inhibition
dc.subjecthydrogen bond
dc.subjecthydrophobicity
dc.subjectIC50
dc.subjectmass spectrometry
dc.subjectmolecular docking
dc.subjectnonhuman
dc.subjectpi pi stacking interaction
dc.subjectproton nuclear magnetic resonance
dc.subjectstructure activity relation
dc.subjectVero cell line
dc.subjectanimal
dc.subjectcell survival
dc.subjectchemical phenomena
dc.subjectchemistry
dc.subjectChlorocebus aethiops
dc.subjectdrug effects
dc.subjecthuman
dc.subjectsynthesis
dc.subjectAnimals
dc.subjectAntineoplastic Agents
dc.subjectAromatase
dc.subjectAromatase Inhibitors
dc.subjectCatalytic Domain
dc.subjectCell Survival
dc.subjectCercopithecus aethiops
dc.subjectHumans
dc.subjectHydrogen Bonding
dc.subjectHydrophobic and Hydrophilic Interactions
dc.subjectIsoquinolines
dc.subjectMolecular Docking Simulation
dc.subjectProtein Binding
dc.subjectStructure-Activity Relationship
dc.subjectSulfonamides
dc.subjectTriazoles
dc.subjectVero Cells
dc.titleSynthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBioorganic and Medicinal Chemistry. Vol 23, No.13 (2015), p.3472-3480
dc.identifier.doi10.1016/j.bmc.2015.04.036
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.